Literature DB >> 30663027

High frequency of pathogenic and rare sequence variants in diabetes-related genes among Russian patients with diabetes in pregnancy.

Natalia Zubkova1, Fatima Burumkulova2, Margarita Plechanova2, Vasily Petrukhin2, Vasily Petrov3, Evgeny Vasilyev3, Anton Panov2, Ekaterina Sorkina3, Victoria Ulyatovskaya2, Nina Makretskaya3, Anatoly Tiulpakov3.   

Abstract

AIMS: Diabetes in pregnancy may be associated with monogenic defects of beta-cell function, frequency of which depends on ethnicity, clinical criteria for selection of patients as well as methods used for genetic analysis. The aim was to evaluate the contribution and molecular spectrum of mutations among genes associated with monogenic diabetes in non-obese Russian patients with diabetes in pregnancy using the next-generation sequencing (NGS).
METHODS: 188 non-obese pregnant women with diabetes during pregnancy were included in the study; among them 57 subjects (30.3%) met the American Diabetes Association (ADA) criteria of preexisting pregestational diabetes (pre-GDM), whereas 131 women (69.7%) fulfilled criteria of gestational diabetes mellitus (GDM). A custom NGS panel targeting 28 diabetes causative genes was used for sequencing. The sequence variants were rated according to the American College of Medical Genetics and Genomics (ACMG) guidelines.
RESULTS: In total, 23 pathogenic, 18 likely pathogenic and 16 variants of uncertain significance were identified in 59/188 patients (31.4%). The majority of variants (38/59) were found in GCK gene. No significant differences in the number of variants among the two study groups (pre-GDM and GDM) were observed.
CONCLUSIONS: The study suggests that frequency of monogenic variants of diabetes might be underestimated, which warrants a broader use of genetic testing, especially in pregnancy.

Entities:  

Keywords:  Diabetes in pregnancy; Monogenic forms of diabetes; Next-generation sequencing; Non-obese pregnant women

Mesh:

Substances:

Year:  2019        PMID: 30663027     DOI: 10.1007/s00592-018-01282-6

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  4 in total

Review 1.  How Recent Advances in Genomics Improve Precision Diagnosis and Personalized Care of Maturity-Onset Diabetes of the Young.

Authors:  Martine Vaxillaire; Philippe Froguel; Amélie Bonnefond
Journal:  Curr Diab Rep       Date:  2019-08-05       Impact factor: 4.810

2.  Whole‑exome sequencing in Russian children with non‑type 1 diabetes mellitus reveals a wide spectrum of genetic variants in MODY‑related and unrelated genes.

Authors:  Oleg S Glotov; Elena A Serebryakova; Mariia E Turkunova; Olga A Efimova; Andrey S Glotov; Yury A Barbitoff; Yulia A Nasykhova; Alexander V Predeus; Dmitrii E Polev; Mikhail A Fedyakov; Irina V Polyakova; Tatyana E Ivashchenko; Natalia Y Shved; Elena S Shabanova; Alena V Tiselko; Olga V Romanova; Andrey M Sarana; Anna A Pendina; Sergey G Scherbak; Ekaterina V Musina; Anastasiia V Petrovskaia-Kaminskaia; Liubov R Lonishin; Liliya V Ditkovskaya; Liudmila А Zhelenina; Ludmila V Tyrtova; Olga S Berseneva; Rostislav K Skitchenko; Evgenii N Suspitsin; Elena B Bashnina; Vladislav S Baranov
Journal:  Mol Med Rep       Date:  2019-10-16       Impact factor: 2.952

3.  First Japanese Family With PDX1-MODY (MODY4): A Novel PDX1 Frameshift Mutation, Clinical Characteristics, and Implications.

Authors:  Satoshi Yoshiji; Yukio Horikawa; Sodai Kubota; Mayumi Enya; Yorihiro Iwasaki; Yamato Keidai; Megumi Aizawa-Abe; Kanako Iwasaki; Sachiko Honjo; Kazuyoshi Hosomichi; Daisuke Yabe; Akihiro Hamasaki
Journal:  J Endocr Soc       Date:  2021-10-17

Review 4.  Genomics and Epigenomics of Gestational Diabetes Mellitus: Understanding the Molecular Pathways of the Disease Pathogenesis.

Authors:  Nadia Abu Samra; Herbert F Jelinek; Habiba Alsafar; Farah Asghar; Muhieddine Seoud; Shahad M Hussein; Hisham M Mubarak; Siddiq Anwar; Mashal Memon; Nariman Afify; Ridda Manzoor; Zahrah Al-Homedi; Wael Osman
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.